Search research articles
Contact Us
Filters
Showing results (131-140 of 197) with videos related to
Page
of 20
Sort By:
Clinical Pharmacology and Therapeutics
|
April 1, 1990
Concentration-response relationship in imipramine treatment of diabetic neuropathy symptoms
S H Sindrup, L F Gram, T Skjold, et al.
Psychopharmacology Series
|
January 1, 1993
Role of genetic polymorphism in psychopharmacology--an update
K Brøsen, S H Sindrup, E Skjelbo, et al.
Clinical Pharmacology and Therapeutics
|
June 1, 1991
Sparteine and mephenytoin oxidation: genetic polymorphisms in east and west Greenland
K Clasen, L Madsen, K Brøsen, et al.
Journal of Affective Disorders
|
March 3, 2012
The predictive validity of atypical neurovegetative depressive symptoms identified by the first principal component in the DUAG trial of moclobemide versus clomipramine
P Bech, K B Stage, J K Larsen, et al.
Acta Psychiatrica Scandinavica
|
March 1, 1975
Quantitative rating of depressive states
P Bech, L F Gram, E Dein, et al.
European Journal of Clinical Pharmacology
|
January 1, 1996
Dose-dependent inhibition of CYP1A2, CYP2C19 and CYP2D6 by citalopram, fluoxetine, fluvoxamine and paroxetine
U Jeppesen, L F Gram, K Vistisen, et al.
Ugeskrift for Laeger
|
January 26, 1981
[Management of the therapy of depression with tricyclic antidepressive agents]
L F Gram, P Kragh-Sørensen, A Nagy, et al.
Therapeutic Drug Monitoring
|
January 1, 1982
Drug level monitoring in psychopharmacology: usefulness and clinical problems, with special reference to tricyclic antidepressants
L F Gram, O L Pedersen, C B Kristensen, et al.
Psychopharmacology
|
January 1, 1985
Orthostatic side effects of clomipramine and citalopram during treatment for depression
P Christensen, H Y Thomsen, O L Pedersen, et al.
Journal of Internal Medicine
|
January 1, 1991
Drugs and femoral neck fracture: a case-control study
J Jensen, L H Nielsen, N Lyhne, et al.
Page
of 20
Search research articles
Search
Showing results (131-140 of 197) with videos related to
Sort By:
Page
of 20
Clinical Pharmacology and Therapeutics
|
April 1, 1990
Concentration-response relationship in imipramine treatment of diabetic neuropathy symptoms
S H Sindrup, L F Gram, T Skjold, et al.
Psychopharmacology Series
|
January 1, 1993
Role of genetic polymorphism in psychopharmacology--an update
K Brøsen, S H Sindrup, E Skjelbo, et al.
Clinical Pharmacology and Therapeutics
|
June 1, 1991
Sparteine and mephenytoin oxidation: genetic polymorphisms in east and west Greenland
K Clasen, L Madsen, K Brøsen, et al.
Journal of Affective Disorders
|
March 3, 2012
The predictive validity of atypical neurovegetative depressive symptoms identified by the first principal component in the DUAG trial of moclobemide versus clomipramine
P Bech, K B Stage, J K Larsen, et al.
Acta Psychiatrica Scandinavica
|
March 1, 1975
Quantitative rating of depressive states
P Bech, L F Gram, E Dein, et al.
European Journal of Clinical Pharmacology
|
January 1, 1996
Dose-dependent inhibition of CYP1A2, CYP2C19 and CYP2D6 by citalopram, fluoxetine, fluvoxamine and paroxetine
U Jeppesen, L F Gram, K Vistisen, et al.
Ugeskrift for Laeger
|
January 26, 1981
[Management of the therapy of depression with tricyclic antidepressive agents]
L F Gram, P Kragh-Sørensen, A Nagy, et al.
Therapeutic Drug Monitoring
|
January 1, 1982
Drug level monitoring in psychopharmacology: usefulness and clinical problems, with special reference to tricyclic antidepressants
L F Gram, O L Pedersen, C B Kristensen, et al.
Psychopharmacology
|
January 1, 1985
Orthostatic side effects of clomipramine and citalopram during treatment for depression
P Christensen, H Y Thomsen, O L Pedersen, et al.
Journal of Internal Medicine
|
January 1, 1991
Drugs and femoral neck fracture: a case-control study
J Jensen, L H Nielsen, N Lyhne, et al.
Page
of 20